KLOW: uses, dosing & the facts

A comprehensive peptide blend for systemic inflammation and autoimmune support, combining BPC-157, TB-500, GHK-Cu, and KPV. Provides healing (BPC-157/TB-500), collagen synthesis (GHK-Cu), and systemic anti-inflammation (KPV) in one protocol. Best for autoimmune conditions, chronic inflammation, gut issues, and skin problems. This is an evidence-graded reference — what it is, what it's used for, typical reported dosing, half-life, side effects, and how to track it. It is educational, not medical advice or a recommendation to use a research compound.

By OptiPin Editorial·Last updated July 2026

Status

Research use only · not FDA-approved. Reported dosing below reflects community-discussed patterns, presented for information only — not a dose recommendation. For the US regulatory picture on research peptides, see the 2026 FDA compounding status.

Class

Longevity

Used for

Systemic inflammation reduction

Half-life

BPC-157: 4-6 hours. …

Status

Research use only

TL;DR

• KLOW — Longevity. A comprehensive peptide blend for systemic inflammation and autoimmune support, combining BPC-157, TB-500, GHK-Cu, and KPV.
• Commonly used for systemic inflammation reduction, autoimmune condition support, chronic inflammation management.
• Half-life: BPC-157: 4-6 hours. TB-500: 2-3 hours. GHK-Cu: 2-3 hours. KPV: 2-3 hours. Combined effects provide sustained benefits..
• Status: Research use only · not FDA-approved — an educational reference, not a dose protocol or sourcing advice.

What KLOW is

What KLOW is used for

• Systemic inflammation reduction
• Autoimmune condition support
• Chronic inflammation management
• Gut health and gastrointestinal issues
• Skin problem resolution
• Combined healing and anti-inflammatory effects
• Energy improvement in inflammatory conditions

These are reported/community uses, not proven clinical outcomes. Most research peptides have limited human trial data behind such claims.

Typical reported dosing

Injectable

Standard: 500mcg BPC-157 + 500mcg TB-500 + 2mg GHK-Cu + 100-500mcg KPV daily subcutaneously. Typical blend: 10mg BPC-157 + 10mg TB-500 + 50mg GHK-Cu + 10mg KPV per vial.

Presented as commonly-reported patterns for information only — not a dose recommendation. KLOW dosing is a decision for a qualified clinician.

Reconstitution

Reconstitute blend vial with 2mL bacteriostatic water. Standard dose = varies by vial concentration. KPV allows for oral administration as well. Check individual component reconstitution guides. The arithmetic is the same for any peptide: concentration = vial mg ÷ water mL, and on a U-100 syringe 100 units = 1 mL. Compute your own vial with the reconstitution calculator.

Half-life & cycling

Half-life: BPC-157: 4-6 hours. TB-500: 2-3 hours. GHK-Cu: 2-3 hours. KPV: 2-3 hours. Combined effects provide sustained benefits.. Half-life drives dosing frequency and how quickly the compound clears — see it plotted on the half-life visualizer.

Cycling

Typical cycles: 8-12 weeks on, 4 weeks off. Improvements in inflammation and energy within 4-6 weeks. Can be used continuously with breaks for chronic conditions. Requires dietary changes for best results.

Side effects & warnings

• Generally well-tolerated
• Mild injection site irritation possible
• Minimal side effects when used appropriately
• Very safe profile

Research use only. Comprehensive inflammation and autoimmune support stack. Requires dietary changes - peptides alone won't override triggering foods. Most effective for autoimmune conditions and chronic inflammation when combined with proper nutrition. KPV provides systemic anti-inflammatory benefits. Synergistic combination addresses multiple aspects of inflammation and healing.

Not a prescription, a dose, or a sourcing guide. KLOW is a research compound; safety and efficacy in humans are not fully established, and research-grade material has no guarantee of purity, sterility, or stated strength. OptiPin is a tracking tool and does not recommend using research chemicals. Discuss any peptide with a qualified clinician.

Tracking KLOW in OptiPin

If you're tracking a KLOW protocol, OptiPin logs each dose with reminders and site rotation, charts the outcome you care about over your dose timeline, keeps per-vial inventory with runout warnings, and (where relevant) does the reconstitution math — all on-device, no account.

Track it properly

Log doses, outcomes & vials in OptiPin

Reminders, outcome-over-dose charts, vial runout warnings, and built-in reconstitution math — all on-device.

Download on the App Store

FAQ

What is KLOW?

What is KLOW used for?

Commonly discussed uses include: systemic inflammation reduction, autoimmune condition support, chronic inflammation management, gut health and gastrointestinal issues, skin problem resolution, combined healing and anti-inflammatory effects, energy improvement in inflammatory conditions. These are reported uses, not proven outcomes or a recommendation.

How is KLOW dosed?

Commonly reported dosing: Injectable — Standard: 500mcg BPC-157 + 500mcg TB-500 + 2mg GHK-Cu + 100-500mcg KPV daily subcutaneously. Typical blend: 10mg BPC-157 + 10mg TB-500 + 50mg GHK-Cu + 10mg KPV per vial.. This reflects patterns discussed in the community and is presented for information only, not as a dose recommendation — KLOW is not an approved medicine and dosing should involve a qualified clinician.

How do you reconstitute KLOW?

Reconstitute blend vial with 2mL bacteriostatic water. Standard dose = varies by vial concentration. KPV allows for oral administration as well. Check individual component reconstitution guides. On a U-100 syringe, 100 units = 1 mL. Concentrations vary by vial, so compute from your own vial with a reconstitution calculator.

What is KLOW's half-life?

BPC-157: 4-6 hours. TB-500: 2-3 hours. GHK-Cu: 2-3 hours. KPV: 2-3 hours. Combined effects provide sustained benefits.. Half-life shapes how often it is dosed and how quickly it clears.

What are KLOW's side effects?

Reported effects include: generally well-tolerated, mild injection site irritation possible, minimal side effects when used appropriately, very safe profile. Because it is a research compound, its safety profile is not fully characterized; discuss risks with a clinician.

Educational only, not medical advice. KLOW is a research compound and is not an approved medicine for the uses described. OptiPin is a tracking tool and does not provide dosing or treatment advice. Discuss any peptide with a qualified clinician.

Evidence & further reading

Search the peer-reviewed literature for KLOW on PubMed (entry point to the primary evidence base, not a specific citation).
KLOW on ClinicalTrials.gov — registered human trials, if any.
US FDA / 503A compounding status of research peptides (2026).
OptiPin peptides guide — categories, evidence grading, and how to run a protocol honestly.

Pinealon · SS-31 (Elamipretide) · Thymalin · Vilon · nad-plus · Reconstitution calculator · All peptides